Junji Wasa
- Rheumatology top 5%
- Bone Tumor Diagnosis and Treatments 9
- Neurology top 10%
- Neurofibromatosis and Schwannoma Cases 5
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research 4
-
- Sarcoma Diagnosis and Treatment 20
-
- Vascular Tumors and Angiosarcomas 4
-
- Management of metastatic bone disease 8
- Surgical site infection prevention 5
-
- Soft tissue tumors and treatment 4
- Co-authors
- Naoki IshiguroYoshihiro NishidaSatoshi TsukushiEisuke AraiHideshi SugiuraYoji ShidoEiji KozawaHiroshi Urakawa
- Cited by
- RheumatologyNeurologyCell Biology
- Journals
- International Journal of Cancer (2 papers)International Journal of Clinical Oncology (2 papers)Cancer (1 paper)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Junji Wasa
38 papers receiving 882 citations
Peers
Comparison fields: 5 of 67
- Rheumatology 237
- Neurology 189
- Cell Biology 203
- Pulmonary and Respiratory Medicine 338
- Oncology 191
Countries citing papers authored by Junji Wasa
This map shows the geographic impact of Junji Wasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Wasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Wasa more than expected).
Fields of papers citing papers by Junji Wasa
This network shows the impact of papers produced by Junji Wasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Wasa. The network helps show where Junji Wasa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Junji Wasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 2 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 10 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 1 | |
| 10 | 2017 | 2 | |
| 11 | 2016 | 8 | |
| 12 | 2011 | 4 | |
| 13 | 2011 | 128 | |
| 14 | 2011 | 1 | |
| 15 | 2011 | 11 | |
| 16 | 2011 | 44 | |
| 17 | 2011 | 74 | |
| 18 | 2010 | 64 | |
| 19 | 2008 | 12 | |
| 20 | 2003 | 5 |
About Junji Wasa
Junji Wasa is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Oncology, having authored 42 papers that have together received 895 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (20 papers), Bone Tumor Diagnosis and Treatments (9 papers), Management of metastatic bone disease (8 papers), Surgical site infection prevention (5 papers), Neurofibromatosis and Schwannoma Cases (5 papers), Vascular Tumors and Angiosarcomas (4 papers), Soft tissue tumors and treatment (4 papers) and Proteoglycans and glycosaminoglycans research (4 papers). The work is most often cited by research in Rheumatology (237 citations), Neurology (189 citations) and Cell Biology (203 citations). Junji Wasa has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Naoki Ishiguro, Yoshihiro Nishida, Satoshi Tsukushi, Eisuke Arai, Hideshi Sugiura, Yoji Shido, Eiji Kozawa, Hiroshi Urakawa, Hiroatsu Nakashima and Naohisa Futamura. Their work appears in journals such as International Journal of Cancer, International Journal of Clinical Oncology, Cancer, Japanese Journal of Clinical Oncology and Pathology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.